A project on the transformation of the strain of the '17D' vaccine against yellow fever into antibodies for the vaccine against dengue and malaria was presented at the Daniel Comboni Center of the Church of Nuestra Señora del Carmen in Ecuador. The study, by Jesús Camilo Orellana Orellana, was recognized by the Ministries of Health, Defense and the Presidency of Ecuador, and supported by the Department of Medicine of the University of Guayaquil, which provided a team of researchers for the study. The research project will be put into practice in a military hospital.
The laboratories that will collaborate in the preparation of antibodies are one in the coastal city of Guayaquil and in Quito at the Red Cross. The vaccine is intramuscular and half a centimeter in depth, and will be given to persons who were not infected with dengue or malaria. Since early this year, there have already been 13 cases of classical dengue recorded at the Francisco de Icaza Bustamante Hospital in Guayaquil. Last week, four children were hospitalized for hemorrhagic dengue in the same hospital, along with 16 who had classical dengue, in the Department of Infectious Diseases.
According to data from the Pan American Health Organization (PAHO), from 1985 to 2004, 3,559 cases of yellow fever were registered in the northern region of South America. From among these, 2,068 people affected have died. In 2009, there were 574 cases of classic dengue fever along the coast: 164 in Guayas, Los Ríos 156, and 143 in El Oro.
RSS